{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T23:15:45Z","timestamp":1789600545976,"version":"build-2803163510"},"reference-count":139,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T00:00:00Z","timestamp":1626912000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T00:00:00Z","timestamp":1626912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl. Stroke Res."],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Ischemic stroke is the third leading cause of death and disability worldwide, with no available satisfactory prevention or treatment approach. The current treatment is limited to the use of \u201creperfusion methods,\u201d i.e., an intravenous or intra-arterial infusion of a fibrinolytic agent, mechanical removal of the clot by thrombectomy, or a combination of both methods. It should be stressed, however, that only approximately 5% of all acute strokes are eligible for fibrinolytic treatment and fewer than 10% for thrombectomy. Despite the tremendous progress in understanding of the pathomechanisms of cerebral ischemia, the promising results of basic research on neuroprotection are not currently transferable to human stroke. A possible explanation for this failure is that experiments on in vivo animal models involve healthy young animals, and the experimental protocols seldom consider the importance of protecting the whole neurovascular unit (NVU), which ensures intracranial homeostasis and is seriously damaged by ischemia\/reperfusion. One of the endogenous protective systems activated during ischemia and in neurodegenerative diseases is represented by neuropeptide Y (NPY). It has been demonstrated that activation of NPY Y2 receptors (Y2R) by a specific ligand decreases the volume of the postischemic infarction and improves performance in functional tests of rats with arterial hypertension subjected to middle cerebral artery occlusion\/reperfusion. This functional improvement suggests the protection of the NVU. In this review, we focus on NPY and discuss the potential, multidirectional protective effects of Y2R agonists against acute focal ischemia\/reperfusion injury, with special reference to the NVU.<\/jats:p>","DOI":"10.1007\/s12975-021-00930-4","type":"journal-article","created":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T08:03:07Z","timestamp":1626940987000},"page":"12-24","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Ligands of the Neuropeptide Y Y2 Receptors as a Potential Multitarget Therapeutic Approach for the Protection of the Neurovascular Unit Against Acute Ischemia\/Reperfusion: View from the Perspective of the Laboratory Bench"],"prefix":"10.1007","volume":"13","author":[{"given":"\u0141ukasz","family":"Przykaza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0675-1238","authenticated-orcid":false,"given":"Ewa","family":"Kozniewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,22]]},"reference":[{"key":"930_CR1","doi-asserted-by":"crossref","unstructured":"Kim J, Thayabaranathan T, Donnan GA, Howard G, Howard VJ, Rothwell P, et al. Global Stroke Statistics 2019. Int J Stroke. 2020;15(8):819\u2013838.\u00a0","DOI":"10.1177\/1747493020909545"},{"key":"930_CR2","unstructured":"European Stroke Initiative Executive Committee; EUSI Writing Committee, Olsen TS, Langhorne P, Diener HC, Hennerici M, Ferro J, Sivenius J, et al. Cerebrovasc Dis. 2003;16:311\u201337.\u00a0\u00a0"},{"issue":"1","key":"930_CR3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.neurad.2010.09.001","volume":"38","author":"CA Taschner","year":"2011","unstructured":"Taschner CA, Treier M, Schumacher M, Berlis A, Weber J, Niesen W. Mechanical thrombectomy with the penumbra recanalization device in acute ischemic stroke. J Neuroradiol. 2011;38(1):47\u201352.","journal-title":"J Neuroradiol"},{"key":"930_CR4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1053\/j.tvir.2011.12.011","volume":"15","author":"EA Samaniego","year":"2012","unstructured":"Samaniego EA, Linfante I, Dabus G. Intra-arterial thrombolysis: tissue plasminogen activator and other thrombolytic agents. Tech Vasc Interv Radiol. 2012;15:41\u20136.","journal-title":"Tech Vasc Interv Radiol"},{"key":"930_CR5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3389\/fneur.2013.00069","volume":"4","author":"ES Sussman","year":"2013","unstructured":"Sussman ES, Connolly ES Jr. Hemorrhagic transformation: a review of the rate of hemorrhage in the major clinical trials of acute ischemic stroke. Front Neurol. 2013;4:69.","journal-title":"Front Neurol"},{"key":"930_CR6","first-page":"2","volume":"10","author":"Y Suzuki","year":"2016","unstructured":"Suzuki Y, Nagai N, Umemura K. A review of the mechanisms of blood-brain barrier permeability by tissue-type plasminogen activator treatment for cerebral ischemia. Front Cell Neurosci. 2016;10:2.","journal-title":"Front Cell Neurosci"},{"key":"930_CR7","doi-asserted-by":"crossref","first-page":"h4607","DOI":"10.1136\/bmj.h4607","volume":"351","author":"DL Cohen","year":"2015","unstructured":"Cohen DL, Kearney R, Griffiths M, Nadesalingam V, Bathula R. Around 9% of patients with ischaemic stroke are suitable for thrombectomy. BMJ. 2015;351:h4607.","journal-title":"BMJ."},{"key":"930_CR8","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1586\/ern.11.99","volume":"12","author":"EV Kuklina","year":"2012","unstructured":"Kuklina EV, Tong X, George MG, Bansil P. Epidemiology and prevention of stroke: a worldwide perspective. Expert Rev Neurother. 2012;12:199\u2013208.","journal-title":"Expert Rev Neurother"},{"key":"930_CR9","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.neuroscience.2008.08.028","volume":"158","author":"GJ Del Zoppo","year":"2009","unstructured":"Del Zoppo GJ. Inflammation and the neurovascular unit in the setting of focal cerebral ischemia. Neuroscience. 2009;158:972\u201382.","journal-title":"Neuroscience"},{"issue":"7","key":"930_CR10","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/nm.2399","volume":"17","author":"C Iadecola","year":"2012","unstructured":"Iadecola C, Anrather J. The immunology of stroke: from mechanism to translation. Nat Med. 2012;17(7):796\u2013808.","journal-title":"Nat Med"},{"key":"930_CR11","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1161\/01.STR.30.12.2752","volume":"30","author":"Stroke Therapy Academic Industry Roundtable (STAIR)","year":"1999","unstructured":"Stroke Therapy Academic Industry Roundtable (STAIR). Recommendations for standards regarding preclinical neuroprotective and restorative drug development (STAIR). Stroke. 1999;30:2752\u20138.","journal-title":"Stroke"},{"issue":"5","key":"930_CR12","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0166-2236(03)00071-7","volume":"26","author":"U Dirnagl","year":"2003","unstructured":"Dirnagl U, Simon RP, Hallenbeck JM. Ischemic tolerance and endogenous neuroprotection. Trends Neurosci. 2003;26(5):248\u201354.","journal-title":"Trends Neurosci"},{"issue":"8","key":"930_CR13","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S1474-4422(03)00482-4","volume":"2","author":"T H\u00f6kfelt","year":"2003","unstructured":"H\u00f6kfelt T, Bartfai T, Bloom F. Neuropeptides: opportunities for drug discovery. Lancet Neurol. 2003;2(8):463\u201372.","journal-title":"Lancet Neurol"},{"key":"930_CR14","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.2174\/156802607782341037","volume":"7","author":"K Eaton","year":"2007","unstructured":"Eaton K, Sallee FR, Sah R. Relevance of neuropeptide Y (NPY) in psychiatry. Curr Top Med Chem. 2007;7:1645\u201359.","journal-title":"Curr Top Med Chem"},{"key":"930_CR15","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.npep.2012.08.005","volume":"46","author":"P Holzer","year":"2012","unstructured":"Holzer P, Reichmann F, Farzi A. Neuropeptide Y, peptide YY and pancreatic polypeptide in the gut-brain axis. Neuropeptides. 2012;46:261\u201374.","journal-title":"Neuropeptides"},{"key":"930_CR16","first-page":"143","volume":"50","author":"MC Michel","year":"1998","unstructured":"Michel MC, Beck-Sickinger A, Cox H, Doods HN, Herzog H, Larhammar D, et al. XVI. International union of pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol Rev. 1998;50:143\u201350.","journal-title":"Pharmacol Rev"},{"issue":"6","key":"930_CR17","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.neuroscience.2016.12.040","volume":"344","author":"H Domin","year":"2017","unstructured":"Domin H, Przykaza \u0141, Jantas D, Kozniewska E, Boguszewski PM, \u015amia\u0142owska M. Neuropeptide Y Y2 and Y5 receptors as promising targets for neuroprotection in primary neurons exposed to oxygen-glucose deprivation and in transient focal cerebral ischemia in rats. Neuroscience. 2017;344(6):305\u201325.","journal-title":"Neuroscience"},{"issue":"1Suppl","key":"930_CR18","doi-asserted-by":"publisher","first-page":"abs.#452","DOI":"10.1177\/0271678X16639008","volume":"36","author":"L Przykaza","year":"2016","unstructured":"Przykaza L, Domin H, Boguszewski PM, Smialowska M, Kozniewska E. Attenuation of postischemic functional deficits in rats with essential hypertension treated with NPY2R agonist. J Cereb Blood Flow Metab. 2016;36(1Suppl):abs.#452. https:\/\/doi.org\/10.1177\/0271678X16639008.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"930_CR19","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.neuron.2017.07.030","volume":"96","author":"C Iadecola","year":"2017","unstructured":"Iadecola C. The neurovascular unit coming of age: a journey through neurovascular coupling in health and disease. Neuron. 2017;96(1):17\u201342.","journal-title":"Neuron"},{"key":"930_CR20","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1159\/000324328","volume":"31","author":"J Badaut","year":"2011","unstructured":"Badaut J, Ashwal S, Obenaus A. Aquaporins in cerebrovascular disease: a target for treatment of brain edema. Cerebrovasc Dis. 2011;31:521\u201331.","journal-title":"Cerebrovasc Dis"},{"key":"930_CR21","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0166-2236(99)01401-0","volume":"22","author":"U Dirnagl","year":"1999","unstructured":"Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 1999;22:391\u20137.","journal-title":"Trends Neurosci"},{"key":"930_CR22","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/0166-2236(95)80018-W","volume":"18","author":"DW Choi","year":"1996","unstructured":"Choi DW. Ischemia-induced neuronal death. Trends Neurosci. 1996;18:58\u201360.","journal-title":"Trends Neurosci"},{"key":"930_CR23","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1006\/excr.1997.4026","volume":"239","author":"M Leist","year":"1998","unstructured":"Leist M, Nicotera P. Apoptosis, excitotoxicity, and neuropathology. Exp Cell Res. 1998;239:183\u2013201.","journal-title":"Exp Cell Res"},{"issue":"1","key":"930_CR24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/jcbfm.1984.3","volume":"4","author":"WA Mutch","year":"1984","unstructured":"Mutch WA, Hansen AJ. Extracellular pH changes during spreading depression and cerebral ischemia: mechanisms of brain pH regulation. J Cereb Blood Flow Metab. 1984;4(1):17\u201327.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"930_CR25","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/s41598-017-01284-4","volume":"7","author":"\u00c1 Menyh\u00e1rt","year":"2017","unstructured":"Menyh\u00e1rt \u00c1, Z\u00f6lei-Sz\u00e9n\u00e1si D, Pusk\u00e1s T, Makra P, Orsolya MT, Szepes B\u00c9, et al. Spreading depolarization remarkably exacerbates ischemia-induced tissue acidosis in the young and aged rat brain. Sci Rep. 2017;7(1):1154.","journal-title":"Sci Rep"},{"issue":"6","key":"930_CR26","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.cell.2004.08.026","volume":"118","author":"ZG Xiong","year":"2004","unstructured":"Xiong ZG, Zhu XM, Chu XP, Minami M, Hey J, Wei WL, et al. Neuroprotection in ischemia: blocking calcium-permeable acid-sensing ion channels. Cell. 2004;118(6):687\u201398.","journal-title":"Cell"},{"key":"930_CR27","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s12975-013-0319-5","volume":"5","author":"Z O\u2019Bryant","year":"2014","unstructured":"O\u2019Bryant Z, Vann KT, Xiong ZG. Translational strategies for neuroprotection in ischemic stroke- focusing on acid-sensing ion channel 1a. Trans Stroke Res. 2014;5:59\u201368.","journal-title":"Trans Stroke Res"},{"key":"930_CR28","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1152\/physrev.1999.79.3.763","volume":"79","author":"MP Blaustein","year":"1999","unstructured":"Blaustein MP, Lederer WI. Sodium\/calcium exchange: its physiological implications. Physiol Rev. 1999;79:763\u2013854.","journal-title":"Physiol Rev"},{"key":"930_CR29","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1093\/molbev\/msh177","volume":"21","author":"X Cai","year":"2004","unstructured":"Cai X, Lytton J. The cation\/Ca(2+) exchange superfamily: phylogenetic analysis and structural implications. Mol Biol Evol. 2004;21:1692\u2013703.","journal-title":"Mol Biol Evol"},{"key":"930_CR30","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.jocn.2006.07.013","volume":"14","author":"GJ Jeffs","year":"2007","unstructured":"Jeffs GJ, Meloni BP, Bakker AJ, Knuckey NW. The role of the Na(+)\/Ca(2+) exchanger (NCX) in neurons following ischaemia. J Clin Neurosci. 2007;14:507\u201314.","journal-title":"J Clin Neurosci"},{"key":"930_CR31","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1161\/STROKEAHA.106.478644","volume":"38","author":"A Tortiglione","year":"2007","unstructured":"Tortiglione A, Picconi B, Barone I, Centonze D, Rossi S, Costa C, et al. Na+\/Ca2+ exchanger maintains ionic homeostasis in the peri-infarct area. Stroke. 2007;38:1614\u201320.","journal-title":"Stroke"},{"issue":"9","key":"930_CR32","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1523\/JNEUROSCI.4912-07.2008","volume":"28","author":"O Cuomo","year":"2008","unstructured":"Cuomo O, Gala R, Pignataro G, Boscia F, Secondo A, Scorziello A, et al. A critical role for the potassium-dependent sodium\u2013calcium exchanger NCKX2 in protection against focal ischemic brain damage. J Neurosci. 2008;28(9):2053\u201363.","journal-title":"J Neurosci"},{"issue":"2","key":"930_CR33","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/glia.20275","volume":"53","author":"C Matute","year":"2006","unstructured":"Matute C, Domercq M, S\u00e1nchez-G\u00f3mez MV. Glutamate-mediated glial injury: mechanisms and clinical importance. Glia. 2006;53(2):212\u201324.","journal-title":"Glia"},{"key":"930_CR34","first-page":"296","volume-title":"Tomita M","author":"E Ko\u017aniewska","year":"2001","unstructured":"Ko\u017aniewska E, Lisdat F, Ge B, Reszka R. Impact of focal cerebral ischemia \/reperfusion on the regulation of microcirculation in the cerebral cortex in rats. In: Fukuuchi Y, editor. Tomita M. Ischemic blood flow in the brain. Keio University Symposia for Life Science and Medicine. Tokyo: Springer; 2001. p. 296\u2013303."},{"key":"930_CR35","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1097\/01.WCB.0000078322.96027.78","volume":"23","author":"GJ del Zoppo","year":"2003","unstructured":"del Zoppo GJ, Mabuchi T. Cerebral microvessel responses to focal ischemia. J Cereb Blood Flow Metab. 2003;23:879\u201394.","journal-title":"J Cereb Blood Flow Metab"},{"key":"930_CR36","first-page":"S1","volume":"2011","author":"SM Palomares","year":"2011","unstructured":"Palomares SM, Cipolla MJ. Vascular protection following cerebral ischemia and reperfusion. J Neurol Neurophysiol. 2011;2011:S1-004.","journal-title":"J Neurol Neurophysiol"},{"issue":"1","key":"930_CR37","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/jcbfm.2010.191","volume":"31","author":"M Lauritzen","year":"2011","unstructured":"Lauritzen M, Dreier JP, Fabricius M, Hartings JA, Graf R, Strong AJ. Clinical relevance of cortical spreading depression in neurological disorders: migraine, malignant stroke, subarachnoid and intracranial hemorrhage, and traumatic brain injury. J Cereb Blood Flow Metab. 2011;31(1):17\u201335.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"6","key":"930_CR38","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nrn3770","volume":"15","author":"D Pietrobon","year":"2014","unstructured":"Pietrobon D, Moskowitz MA. Chaos and commotion in the wake of cortical spreading depression and spreading depolarizations. Nat Rev Neurosci. 2014;15(6):379\u201393.","journal-title":"Nat Rev Neurosci"},{"key":"930_CR39","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1172\/JCI200421227","volume":"113","author":"Y Gursoy-Ozdemir","year":"2004","unstructured":"Gursoy-Ozdemir Y, Qiu J, Matsuoka N, Bolay H, Bermpohl D, Jin H, et al. Cortical spreading depression activates and upregulates MMP-9. J Clin Invest. 2004;113:1447\u201355.","journal-title":"J Clin Invest"},{"issue":"Pt 4","key":"930_CR40","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1093\/brain\/awp338","volume":"133","author":"JC Chang","year":"2010","unstructured":"Chang JC, Shook LL, Biag J, Nguyen EN, Toga AW, Charles AC, et al. Biphasic direct current shift, haemoglobin desaturation and neurovascular uncoupling in cortical spreading depression. Brain. 2010;133(Pt 4):996\u20131012.","journal-title":"Brain"},{"key":"930_CR41","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nbd.2018.07.026","volume":"119","author":"\u00c1 Menyh\u00e1rt","year":"2018","unstructured":"Menyh\u00e1rt \u00c1, Farkas AE, Varga DP, Frank R, Toth R, Balint A. Large-conductance Ca2+-activated potassium channels are potently involved in the inverse neurovascular response to spreading depolarization. Neurobiol Dis. 2018;119:41\u201352.","journal-title":"Neurobiol Dis"},{"key":"930_CR42","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1365-2796.2009.02199.x","volume":"267","author":"GJ del Zoppo","year":"2010","unstructured":"del Zoppo GJ. The neurovascular unit in the setting of stroke. J Int Med. 2010;267:156\u201371.","journal-title":"J Int Med"},{"issue":"10","key":"930_CR43","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1097\/00004647-199710000-00006","volume":"17","author":"J Aronowski","year":"1997","unstructured":"Aronowski J, Strong R, Grotta JC. Reperfusion injury: demonstration of brain damage produced by reperfusion after transient focal ischemia in rats. J Cereb Blood Flow Metab. 1997;17(10):1048\u201356.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"4","key":"930_CR44","first-page":"199","volume":"4","author":"S Kuroda","year":"1997","unstructured":"Kuroda S, Siesj\u00f6 BK. Reperfusion damage following cerebral ischemia: pathophysiology and therapeutic windows. Clin Neurosci. 1997;4(4):199\u2013212.","journal-title":"Clin Neurosci"},{"issue":"4","key":"930_CR45","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.pathophys.2017.09.003","volume":"24","author":"DN Granger","year":"2017","unstructured":"Granger DN, Kvietys PR. Reperfusion therapy-what\u2019s with the obstructed, leaky and broken capillaries? Pathophysiology. 2017;24(4):213\u201328.","journal-title":"Pathophysiology"},{"issue":"12","key":"930_CR46","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1097\/00004647-199912000-00003","volume":"19","author":"M Bastide","year":"1999","unstructured":"Bastide M, Bordet R, Pu Q, Robin E, Puisieux F, Dupuis B. Relationship between inward rectifier potassium current impairment and brain injury after cerebral ischemia\/reperfusion. J Cereb Blood Flow Metab. 1999;19(12):1309\u201315.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"5","key":"930_CR47","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00210-004-0966-x","volume":"370","author":"O P\u00e9trault","year":"2004","unstructured":"P\u00e9trault O, Bastide M, Cotelle N, Gel\u00e9 P, Gautier S, Laprais M, et al. The neuroprotective effect of the antioxidant flavonoid derivate di-tert-butylhydroxyphenyl is parallel to the preventive effect on post-ischemic Kir2.x impairment but not to post-ischemic endothelial dysfunction. Naunyn Schmiedebergs Arch Pharmacol. 2004;370(5):395\u2013403.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"5","key":"930_CR48","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/00004647-200405000-00006","volume":"24","author":"I Seitz","year":"2004","unstructured":"Seitz I, Dirnagl U, Lindauer U. Impaired vascular reactivity of isolated rat middle cerebral artery after cortical spreading depression in vivo. J Cereb Blood Flow Metab. 2004;24(5):526\u201330.","journal-title":"J Cereb Blood Flow Metab"},{"key":"930_CR49","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1046\/j.1460-9568.2003.02876.x","volume":"18","author":"J Jourquin","year":"2003","unstructured":"Jourquin J, Tremblay E, Decanis N, Charton G, Hanessian S, Chollet AM, et al. Neuronal activity-dependent increase of net matrix metalloproteinase activity is associated with MMP-9 neurotoxicity after kainite. Eur J Neurosci. 2003;18:1507\u201317.","journal-title":"Eur J Neurosci"},{"issue":"6","key":"930_CR50","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.pneurobio.2007.07.008","volume":"83","author":"W Pan","year":"2008","unstructured":"Pan W, Kastin AJ. Tumor necrosis factor and stroke: role of the blood-brain barrier. Progress Neurobiol. 2008;83(6):363\u201374.","journal-title":"Progress Neurobiol"},{"key":"930_CR51","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1161\/01.STR.31.5.1153","volume":"31","author":"LS Ritter","year":"2000","unstructured":"Ritter LS, Orozco JA, Coull BM, McDonagh PF, Rosenblum WI. Leukocyte accumulation and hemodynamic changes in the cerebral microcirculation during early reperfusion after stroke. Stroke. 2000;31:1153\u201361.","journal-title":"Stroke"},{"key":"930_CR52","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1161\/01.ATV.0000167524.69092.16","volume":"25","author":"JA Zeller","year":"2005","unstructured":"Zeller JA, Lenz A, Eschenfelder CC, Zunker P, Deuschl G. Platelet-leukocyte interaction and platelet activation in acute stroke with and without preceding infection. Arterioscler Thromb Vasc Biol. 2005;25:1519\u201323.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"930_CR53","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1161\/01.STR.25.1.202","volume":"25","author":"Y Okada","year":"1994","unstructured":"Okada Y, Copeland BR, Mori E, Tung MM, Thomas WS, del Zoppo GJ. P-selection and intercellular adhesion molecule-1 expression after focal cerebral ischemia and reperfusion. Stroke. 1994;25:202\u201311.","journal-title":"Stroke"},{"issue":"3","key":"930_CR54","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00075198-200206000-00008","volume":"8","author":"VS Ten","year":"2002","unstructured":"Ten VS, Pinsky DJ. Endothelial response to hypoxia: physiologic adaptation and pathologic dysfunction. Curr Opin Crit Care. 2002;8(3):242\u201350.","journal-title":"Curr Opin Crit Care"},{"issue":"1","key":"930_CR55","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.brainres.2006.06.082","volume":"1111","author":"AA Miller","year":"2006","unstructured":"Miller AA, Dusting GJ, Roulston CL, Sobey CG. NADPH-oxidase activity is elevated in penumbral and non-ischemic cerebral arteries following stroke. Brain Res. 2006;1111(1):11\u20136.","journal-title":"Brain Res"},{"issue":"12","key":"930_CR56","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1089\/ars.2012.4797","volume":"18","author":"KA Radermacher","year":"2013","unstructured":"Radermacher KA, Wingler K, Langhauser F, Altenh\u00f6fer S, Kleikers P, Hermans JJ, et al. Neuroprotection after stroke by targeting NOX4 as a source of oxidative stress. Antioxid Redox Signal. 2013;18(12):1418\u201327.","journal-title":"Antioxid Redox Signal"},{"key":"930_CR57","doi-asserted-by":"crossref","first-page":"C1424","DOI":"10.1152\/ajpcell.1996.271.5.C1424","volume":"271","author":"JS Beckman","year":"1996","unstructured":"Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad and ugly. Am J Physiol. 1996;271:C1424-37.","journal-title":"Am J Physiol"},{"key":"930_CR58","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0166-2236(96)10074-6","volume":"20","author":"C Iadecola","year":"1997","unstructured":"Iadecola C. Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci. 1997;20:132\u20139.","journal-title":"Trends Neurosci"},{"key":"930_CR59","first-page":"339","volume":"71","author":"JS Beckman","year":"1996","unstructured":"Beckman JS, Ye YZ, Chen J, Conger K. The interactions of nitric oxide with oxygen radicals and scavengers in cerebral ischemic injury. Adv Neurol. 1996;71:339\u201350.","journal-title":"Adv Neurol"},{"key":"930_CR60","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.2174\/156802607782340948","volume":"7","author":"K Abe","year":"2007","unstructured":"Abe K, Tilan JU, Zukowska Z. NPY and NPY receptors in vascular remodeling. Curr Top Med Chem. 2007;7:1704\u20139.","journal-title":"Curr Top Med Chem"},{"key":"930_CR61","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.yjmcc.2010.08.022","volume":"4996","author":"MP Robich","year":"2010","unstructured":"Robich MP, Matyal R, Chu LM, Feng J, Xu S-H, Laham RJ, et al. Effects of NPY on collateral development in a swine model of chronic myocardial ischemia. J Mol Cell Cardiol. 2010;4996:1022\u201330.","journal-title":"J Mol Cell Cardiol"},{"issue":"3","key":"930_CR62","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/j.1432-1033.1997.t01-1-00780.x","volume":"246","author":"M Labelle","year":"1997","unstructured":"Labelle M, St-Pierre S, Savard R, Boulanger Y. Solution structure of neuropeptide tyrosine 13\u201336, a Y2 receptor agonist, as determined by NMR. Eur J Biochem. 1997;246(3):780\u20135.","journal-title":"Eur J Biochem"},{"issue":"2","key":"930_CR63","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.bmcl.2013.11.061","volume":"24","author":"GK Mittapalli","year":"2014","unstructured":"Mittapalli GK, Roberts E. Ligands of the neuropeptide Y Y2 receptor. Bioorg Med Chem Lett. 2014;24(2):430\u201341.","journal-title":"Bioorg Med Chem Lett"},{"issue":"3","key":"930_CR64","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1006\/geno.1996.0642","volume":"38","author":"DA Ammar","year":"1996","unstructured":"Ammar DA, Eadie DM, Wong DJ, Ma Y, Kolakowski LF Jr, Yang-Feng TL. Characterization of the human type 2 neuropeptide Y receptor gene (NPY2R) and localization to the chromosome 4q region containing the type 1 neuropeptide Y receptor gene. Genomics. 1996;38(3):392\u20138.","journal-title":"Genomics"},{"issue":"2","key":"930_CR65","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0005-2736(96)00166-6","volume":"1284","author":"M Nakamura","year":"1996","unstructured":"Nakamura M, Aoki Y, Hirano D. Cloning and functional expression of a cDNA encoding a mouse type 2 neuropeptide Y receptor. Biochim Biophys Acta. 1996;1284(2):134\u20137.","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"930_CR66","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1006\/geno.1997.4698","volume":"41","author":"CM Lutz","year":"1997","unstructured":"Lutz CM, Frankel WN, Richards J, Thompson DA. Neuropeptide Y receptor genes on human chromosome 4q31-q32 map to conserved linkage groups on mouse chromosomes 3 and 8. Genomics. 1997;41(3):498\u2013500.","journal-title":"Genomics"},{"issue":"1","key":"930_CR67","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1124\/mol.60.1.124","volume":"60","author":"M Goumain","year":"2001","unstructured":"Goumain M, Voisin T, Lorinet AM, Ducroc R, Tsocas A, Roz\u00e9 C. The peptide YY-preferring receptor mediating inhibition of small intestinal secretion is a peripheral Y(2) receptor: pharmacological evidence and molecular cloning. Mol Pharmacol. 2001;60(1):124\u201334.","journal-title":"Mol Pharmacol"},{"issue":"3","key":"930_CR68","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0167-0115(96)00110-3","volume":"65","author":"D Larhammar","year":"1996","unstructured":"Larhammar D. Structural diversity of receptors for neuropeptide Y, peptide YY and pancreatic polypeptide. Regul Pept. 1996;65(3):165\u201374.","journal-title":"Regul Pept"},{"issue":"1","key":"930_CR69","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0306-4522(98)00039-6","volume":"86","author":"L Caberlotto","year":"1998","unstructured":"Caberlotto L, Fuxe K, Rimland JM, Sedvall G, Hurd YL. Regional distribution of neuropeptide Y Y2 receptor messenger RNA in the human post mortem brain. Neuroscience. 1998;86(1):167\u201378.","journal-title":"Neuroscience"},{"issue":"4","key":"930_CR70","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1046\/j.1460-9568.1999.00553.x","volume":"11","author":"RM Parker","year":"1999","unstructured":"Parker RM, Herzog H. Regional distribution of Y-receptor subtype mRNAs in rat brain. Eur J Neurosci. 1999;11(4):1431\u201348.","journal-title":"Eur J Neurosci"},{"issue":"3","key":"930_CR71","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jchemneu.2003.07.003","volume":"26","author":"JL Shaw","year":"2003","unstructured":"Shaw JL, Gackenheimer SL, Gehlert DR. Functional autoradiography of neuropeptide Y Y1 and Y2 receptor subtypes in rat brain using agonist stimulated [35S]GTPgammaSbinding. J Chem Neuroanat. 2003;26(3):179\u201393.","journal-title":"J Chem Neuroanat"},{"key":"930_CR72","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cmet.2005.08.003","volume":"2","author":"M Ghamari-Langroudi","year":"2005","unstructured":"Ghamari-Langroudi M, Colmers WF, Cone RD. PYY3\u201336 inhibits the action potential firing activity of POMC neurons of arcuate nucleus through postsynaptic Y2 receptors. Cell Metab. 2005;2:191\u20139.","journal-title":"Cell Metab"},{"issue":"7","key":"930_CR73","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1002\/cne.22608","volume":"519","author":"D Stani\u0107","year":"2011","unstructured":"Stani\u0107 D, Mulder J, Watanabe M, H\u00f6kfelt T. Characterization of NPY Y2 receptor protein expression in the mouse brain. II. Coexistence with NPY, the Y1 receptor, and other neurotransmitter-related molecules. J Comp Neurol. 2011;519(7):1219\u201357.","journal-title":"J Comp Neurol"},{"issue":"6","key":"930_CR74","doi-asserted-by":"crossref","first-page":"3958","DOI":"10.1523\/JNEUROSCI.14-06-03958.1994","volume":"14","author":"PW Mantyh","year":"1994","unstructured":"Mantyh PW, Allen CJ, Rogers S, DeMaster E, Ghilardi JR, Mosconi T, et al. Some sensory neurons express neuropeptide Y receptors: potential paracrine inhibition of primary afferent nociceptors following peripheral nerve injury. J Neurosci. 1994;14(6):3958\u201368.","journal-title":"J Neurosci"},{"issue":"2","key":"930_CR75","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00004647-199902000-00007","volume":"19","author":"R Abounader","year":"1999","unstructured":"Abounader R, Elhusseiny A, Cohen Z, Olivier A, Stanimirovic D, Quirion R, et al. Expression of neuropeptide Y receptors mRNA and protein in human brain vessels and cerebromicrovascular cells in culture. J Cereb Blood Flow Metab. 1999;19(2):155\u201363.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"930_CR76","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/00004647-200101000-00010","volume":"21","author":"J You","year":"2001","unstructured":"You J, Edvinsson L, Bryan RM Jr. Neuropeptide Y-mediated constriction and dilation in rat middle cerebral arteries. J Cereb Blood Flow Metab. 2001;21(1):77\u201384.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"2\u20133","key":"930_CR77","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0165-0173(97)00052-0","volume":"26","author":"T H\u00f6kfelt","year":"1998","unstructured":"H\u00f6kfelt T, Broberger C, Zhang X, Diez M, Kopp J, Xu Z, et al. Neuropeptide Y: some viewpoints on a multifaceted peptide in the normal and diseased nervous system. Brain Res Rev. 1998;26(2\u20133):154\u201366.","journal-title":"Brain Res Rev"},{"key":"930_CR78","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.npep.2015.09.008","volume":"55","author":"F Reichmann","year":"2016","unstructured":"Reichmann F, Holzer P. Neuropeptide Y: a stressful review. Neuropeptides. 2016;55:99\u2013109.","journal-title":"Neuropeptides"},{"key":"930_CR79","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/emmm.201000100","volume":"2","author":"SP Brothers","year":"2010","unstructured":"Brothers SP, Wahlestedt C. Therapeutic potential of neuropeptide Y (NPY) receptor ligands. EMBO Mol Med. 2010;2:429\u201339.","journal-title":"EMBO Mol Med"},{"key":"930_CR80","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.npep.2015.09.007","volume":"55","author":"RO Tasan","year":"2016","unstructured":"Tasan RO, Verma D, Wood J, Lach G, H\u00f6rmer B, de Lima TC, et al. The role of Neuropeptide Y in fear conditioning and extinction. Neuropeptides. 2016;55:111\u201326.","journal-title":"Neuropeptides"},{"issue":"3","key":"930_CR81","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.npep.2009.02.002","volume":"43","author":"M Smialowska","year":"2009","unstructured":"Smialowska M, Domin H, Zieba B, Ko\u017aniewska E, Michalik R, Piotrowski P, et al. Neuroprotective effects of neuropeptide Y-Y2 and Y5 receptor agonists in vitro and in vivo. Neuropeptides. 2009;43(3):235\u201349.","journal-title":"Neuropeptides"},{"key":"930_CR82","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/0306-4522(95)00198-R","volume":"68","author":"GV Allen","year":"1995","unstructured":"Allen GV, Cheung RT, Cechetto DF. Neurochemical changes following occlusion of the middle cerebral artery in rats. Neuroscience. 1995;68:1037\u201350.","journal-title":"Neuroscience"},{"key":"930_CR83","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JPT Higgins","year":"2003","unstructured":"Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557\u201360.","journal-title":"BMJ"},{"key":"930_CR84","doi-asserted-by":"crossref","unstructured":"Higgins JPT, Li T, Deeks JJ. Choosing effect measures and computing estimates of effect. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, J. Page MJ, Welch VA, editors. Cochrane handbook for systematic reviews of interventions. The Cochrane Collaboration and John Wiley & Sons Ltd.; 2019. pp. 149\u201350.","DOI":"10.1002\/9781119536604.ch6"},{"issue":"10","key":"930_CR85","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/spc3.12267","volume":"10","author":"JX Goh","year":"2016","unstructured":"Goh JX, Hall JA, Rosenthal R. Mini meta-analysis of your own studies: some arguments on why and a primer on how. Soc Pers Psyc Comp. 2016;10(10):535\u201349.","journal-title":"Soc Pers Psyc Comp"},{"key":"930_CR86","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/00004647-199802000-00001","volume":"18","author":"N Fukuyama","year":"1998","unstructured":"Fukuyama N, Takizawa S, Ishida H, Hoshiai K, Shinohara Y, Nakazawa H. Peroxynitrite formation in focal cerebral ischemia-reperfusion in rats occurs predominantly in the peri-infarct region. J Cereb Blood Flow Metab. 1998;18:123\u20139.","journal-title":"J Cereb Blood Flow Metab"},{"key":"930_CR87","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/jcbfm.1995.30","volume":"15","author":"RH Fabian","year":"1995","unstructured":"Fabian RH, DeWitt DS, Kent TA. In vivo detection of superoxide anion production by the brain using a cytochrome c electrode. J Cereb Blood Flow Metab. 1995;15:242\u20137.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"10","key":"930_CR88","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1038\/jcbfm.2013.112","volume":"33","author":"Y Yagita","year":"2013","unstructured":"Yagita Y, Kitagawa K, Oyama N, Yukami T, Watanabe A, Sasaki T, et al. Functional deterioration of endothelial nitric oxide synthase after focal cerebral ischemia. J Cereb Blood Flow Metab. 2013;33(10):1532\u20139.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"3","key":"930_CR89","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1161\/01.CIR.95.3.553","volume":"95","author":"AM Lefer","year":"1997","unstructured":"Lefer AM. Nitric oxide: nature\u2019s naturally occurring leukocyte inhibitor. Circulation. 1997;95(3):553\u20134.","journal-title":"Circulation"},{"key":"930_CR90","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/374421a0","volume":"374","author":"DM Cooper","year":"1995","unstructured":"Cooper DM, Mons N, Karpen JW. Adenylyl cyclases and the interaction between calcium and cAMP signaling. Nature. 1995;374:421\u20134.","journal-title":"Nature"},{"issue":"6","key":"930_CR91","first-page":"253","volume":"3","author":"LB Bergantin","year":"2015","unstructured":"Bergantin LB, Jurkiewicz A, Garcia AG, Caricati-Neto A. A calcium paradox in the context of neurotransmission. J Pharm Pharmacol. 2015;3(6):253\u201361.","journal-title":"J Pharm Pharmacol"},{"issue":"1","key":"930_CR92","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1523\/JNEUROSCI.14-01-00310.1994","volume":"14","author":"LE Chavez-Noriega","year":"1994","unstructured":"Chavez-Noriega LE, Stevens CF. Increased transmitter release at excitatory synapses produced by direct activation of adenylate cyclase in rat hippocampal slices. J Neurosci. 1994;14(1):310\u20137.","journal-title":"J Neurosci"},{"issue":"5424","key":"930_CR93","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1126\/science.285.5424.93","volume":"285","author":"RS Westphal","year":"1999","unstructured":"Westphal RS, Tavalin SJ, Lin JW, Alto NM, Fraser ID, Langeberg LK, et al. Regulation of NMDA receptors by an associated phosphatase-kinase signaling complex. Science. 1999;285(5424):93\u20136.","journal-title":"Science"},{"issue":"3","key":"930_CR94","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.baga.2013.08.001","volume":"3","author":"S Threlfell","year":"2013","unstructured":"Threlfell S, West AR. Review: Modulation of striatal neuron activity by cyclic nucleotide signaling and phosphodiesterase inhibition. Basal Ganglia. 2013;3(3):137\u201346.","journal-title":"Basal Ganglia"},{"issue":"3 Pt 1","key":"930_CR95","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1523\/JNEUROSCI.15-03-01704.1995","volume":"15","author":"CS Colwell","year":"1995","unstructured":"Colwell CS, Levine MS. Excitatory synaptic transmission in neostriatal neurons: regulation by cyclic AMP-dependent mechanisms. J Neurosci. 1995;15(3 Pt 1):1704\u201313.","journal-title":"J Neurosci"},{"issue":"3","key":"930_CR96","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1124\/jpet.108.146332","volume":"328","author":"S Threlfell","year":"2009","unstructured":"Threlfell S, Sammut S, Menniti FS, Schmidt CJ, West AR. Inhibition of phosphodiesterase 10A increases the responsiveness of striatal projection neurons to cortical stimulation. J Pharmacol Exp Ther. 2009;328(3):785\u201395.","journal-title":"J Pharmacol Exp Ther"},{"key":"930_CR97","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BF03159982","volume":"17","author":"K Doma\u0144ska-Janik","year":"1992","unstructured":"Doma\u0144ska-Janik K, Pylova S. Postreceptor modulation of cAMP accumulation in rat brain particulate fraction after ischemia \u2013 involvement of protein kinase C. Mol Chem Neuropathol. 1992;17:65\u201377.","journal-title":"Mol Chem Neuropathol"},{"key":"930_CR98","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.neuropharm.2019.01.014","volume":"148","author":"Q Wang","year":"2019","unstructured":"Wang Q, Zhou FM. cAMP-producing chemogenetic and adenosine A2a receptor activation inhibits the inwardly rectifying potassium current in striatal projection neurons. Neuropharmacology. 2019;148:229\u201343.","journal-title":"Neuropharmacology"},{"issue":"2","key":"930_CR99","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1471-4159.1976.tb04496.x","volume":"26","author":"J Kriv\u00e1nek","year":"1976","unstructured":"Kriv\u00e1nek J. Adenosine 3\u2019,5\u2019-monophosphate in rat cerebral cortex: effect of potassium ions in vivo (cortical spreading depression). J Neurochem. 1976;26(2):413\u20135.","journal-title":"J Neurochem"},{"issue":"2","key":"930_CR100","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/0306-4522(83)90151-3","volume":"10","author":"J Kriv\u00e1nek","year":"1983","unstructured":"Kriv\u00e1nek J. Vanadate and brain adenylate cyclase. Effect of spreading depression. Neuroscience. 1983;10(2):545\u201352.","journal-title":"Neuroscience"},{"issue":"1\u20132","key":"930_CR101","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.neuropharm.2010.04.011","volume":"59","author":"S Tupal","year":"2010","unstructured":"Tupal S, Faingold C. Inhibition of adenylyl cyclase in amygdala blocks the effect of audiogenic seizure kindling in genetically epilepsy-prone rats. Neuropharmacology. 2010;59(1\u20132):107\u201311.","journal-title":"Neuropharmacology"},{"key":"930_CR102","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/glia.10100","volume":"39","author":"T Nishizaki","year":"2002","unstructured":"Nishizaki T, Nagai K, Nomura T, Tada H, Kanno T, Tozaki H, et al. A new neuromodulatory pathway with a glial contribution mediated via A2a adenosine receptors. Glia. 2002;39:133\u201347.","journal-title":"Glia"},{"issue":"4","key":"930_CR103","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neuint.2004.10.006","volume":"46","author":"BA Guillet","year":"2005","unstructured":"Guillet BA, Velly LJ, Canolle B, Masmejean FM, Nieoullon AL, Pisano P. Differential regulation by protein kinases of activity and cell surface expression of glutamate transporters in neuron-enriched cultures. Neurochem Int. 2005;46(4):337\u201346.","journal-title":"Neurochem Int"},{"issue":"16","key":"930_CR104","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1002\/glia.20583","volume":"55","author":"O Adolph","year":"2007","unstructured":"Adolph O, K\u00f6ster S, R\u00e4th M, Georgieff M, Weigt HU, Engele J, et al. Rapid increase of glial glutamate uptake via blockade of the protein kinase A pathway. Glia. 2007;55(16):1699\u2013707.","journal-title":"Glia"},{"issue":"4","key":"930_CR105","doi-asserted-by":"crossref","first-page":"e34936","DOI":"10.1371\/journal.pone.0034936","volume":"7","author":"Y Song","year":"2012","unstructured":"Song Y, Gunnarson E. Potassium dependent regulation of astrocyte water permeability is mediated by cAMP signaling. PLoS One. 2012;7(4):e34936.","journal-title":"PLoS One."},{"issue":"4","key":"930_CR106","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.cell.2020.03.037","volume":"181","author":"P Kitchen","year":"2020","unstructured":"Kitchen P, Salman MM, Halsey AM, Clarke-Bland C, MacDonald JA, Ishida H, et al. Targeting Aquaporin-4 subcellular localizationto treat central nervous system edema. Cell. 2020;181(4):784\u201399.","journal-title":"Cell"},{"issue":"10","key":"930_CR107","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1002\/glia.22853","volume":"63","author":"X Yao","year":"2014","unstructured":"Yao X, Smith AJ, Jin BJ, Zador Z, Manley GT, Verkman AS. Aquaporin-4 regulates the velocity and frequency of cortical spreading depression in mice. Glia. 2014;63(10):1860\u20139.","journal-title":"Glia"},{"issue":"4","key":"930_CR108","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.npep.2004.05.004","volume":"38","author":"A Vezzani","year":"2004","unstructured":"Vezzani A, Sperk G. Overexpression of NPY and Y2 receptors in epileptic brain tissue: an endogenous neuroprotective mechanism in temporal lobe epilepsy? Neuropeptides. 2004;38(4):245\u201352.","journal-title":"Neuropeptides"},{"issue":"9","key":"930_CR109","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1093\/brain\/awq219","volume":"133","author":"DP Woldbye","year":"2010","unstructured":"Woldbye DP, Angehagen M, G\u00f8tzsche CR, Elbr\u00f8nd-Bek H, S\u00f8rensen AT, Christiansen SH, et al. Adeno-associated viral vector-induced overexpression of neuropeptide Y Y2 receptors in the hippocampus suppresses seizures. Brain. 2010;133(9):2778\u201388.","journal-title":"Brain"},{"issue":"2","key":"930_CR110","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.npep.2013.12.003","volume":"48","author":"X Xu","year":"2014","unstructured":"Xu X, Guo F, He Q, Cai X, Min D, Wang Q, et al. Altered expression of neuropeptide Y, Y1 and Y2 receptors, but not Y5 receptor, within hippocampus and temporal lobe cortex of tremor rats. Neuropeptides. 2014;48(2):97\u2013105.","journal-title":"Neuropeptides"},{"issue":"26","key":"930_CR111","doi-asserted-by":"crossref","first-page":"9622","DOI":"10.1523\/JNEUROSCI.3973-14.2015","volume":"35","author":"M Ledri","year":"2015","unstructured":"Ledri M, S\u00f8rensen AT, Madsen MG, Christiansen SH, Ledri LN, Cifra A, et al. Differential effect of neuropeptides on excitatory synaptic transmission in human epileptic hippocampus. J Neurosci. 2015;35(26):9622\u201331.","journal-title":"J Neurosci"},{"issue":"1","key":"930_CR112","doi-asserted-by":"crossref","first-page":"19393","DOI":"10.1038\/s41598-019-56062-1","volume":"9","author":"J Wickham","year":"2019","unstructured":"Wickham J, Ledri M, Bengzon J, Jespersen B, Pinborg LH, Englund E, et al. Inhibition of epileptiform activity by neuropeptide Y in brain tissue from drug-resistant temporal lobe epilepsy patients. Sci Rep. 2019;9(1):19393.","journal-title":"Sci Rep"},{"issue":"32","key":"930_CR113","doi-asserted-by":"crossref","first-page":"7406","DOI":"10.1523\/JNEUROSCI.1008-05.2005","volume":"25","author":"C Acuna-Goycolea","year":"2005","unstructured":"Acuna-Goycolea C, Tamamaki N, Yanagawa Y, Obata K, van den Pol AN. Mechanisms of neuropeptide Y, peptide YY, and pancreatic polypeptide inhibition of identified green fluorescent protein-expressing GABA neurons in the hypothalamic neuroendocrine arcuate nucleus. J Neurosci. 2005;25(32):7406\u201319.","journal-title":"J Neurosci"},{"issue":"9","key":"930_CR114","doi-asserted-by":"crossref","first-page":"e45531","DOI":"10.1371\/journal.pone.0045531","volume":"7","author":"YQ Liu","year":"2012","unstructured":"Liu YQ, Qiu F, Qiu CY, Cai Q, Zou P, Wu H, et al. Cannabinoids inhibit acid-sensing ion channel currents in rat dorsal root ganglion neurons. PLoS One. 2012;7(9):e45531.","journal-title":"PLoS One"},{"issue":"6","key":"930_CR115","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1523\/JNEUROSCI.4351-10.2011","volume":"31","author":"B Duan","year":"2011","unstructured":"Duan B, Wang YZ, Yang T, Chu XP, Yu Y, Huang Y, et al. Extracellular spermine exacerbates ischemic neuronal injury through sensitization of ASIC1a channels to extracellular acidosis. J Neurosci. 2011;31(6):2101\u201312.","journal-title":"J Neurosci"},{"key":"930_CR116","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.bbr.2013.01.039","volume":"244","author":"VV dos Santos","year":"2013","unstructured":"dos Santos VV, Santos DB, Lach G, Rodrigues AL, Farina M, De Lima TC, et al. Neuropeptide Y (NPY) prevents depressive-like behavior, spatial memory deficits and oxidative stress following amyloid-\u03b2 administration in mice. Behav Brain Res. 2013;244:107\u201315.","journal-title":"Behav Brain Res"},{"key":"930_CR117","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/nri2873","volume":"10","author":"GY Chen","year":"2010","unstructured":"Chen GY, Nunez G. Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol. 2010;10:826\u201337.","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"930_CR118","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1128\/JVI.02934-15","volume":"90","author":"TA Woods","year":"2015","unstructured":"Woods TA, Du M, Carmody A, Peterson KE. Neuropeptide Y negatively influences monocyte recruitment to the central nervous system during retrovirus infection. J Virol. 2015;90(6):2783\u201393.","journal-title":"J Virol"},{"key":"930_CR119","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.expneurol.2018.01.001","volume":"302","author":"O Fatoba","year":"2018","unstructured":"Fatoba O, Kloster E, Reick C, Saft C, Gold R, Epplen JT, et al. Activation of NPY-Y2 receptors ameliorates disease pathology in the R6\/2 mouse and PC12 cell models of Huntington\u2019s disease. Exp Neurol. 2018;302:112\u201328.","journal-title":"Exp Neurol"},{"issue":"9","key":"930_CR120","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1111\/j.1460-9568.2012.08232.x","volume":"36","author":"J Gon\u00e7alves","year":"2012","unstructured":"Gon\u00e7alves J, Ribeiro CF, Malva JO, Silva AP. Protective role of neuropeptide Y Y2 receptors in cell death and microglial response following methamphetamine injury. Eur J Neurosci. 2012;36(9):3173\u201383.","journal-title":"Eur J Neurosci"},{"key":"930_CR121","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/01.WCB.0000041283.53351.CB","volume":"23","author":"T Hayashi","year":"2003","unstructured":"Hayashi T, Noshita N, Sugawara T, Chan PH. Temporal profile of angiogenesis and expression of related genes in the brain after ischemia. J Cereb Blood Flow Metab. 2003;23:166\u201380.","journal-title":"J Cereb Blood Flow Metab"},{"key":"930_CR122","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1172\/JCI200317977","volume":"111","author":"Y Sun","year":"2003","unstructured":"Sun Y, Jin K, Xie L, Childs J, Mao XO, Logvinova A, et al. VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J Clin Invest. 2003;111:1843\u201351.","journal-title":"J Clin Invest"},{"issue":"4","key":"930_CR123","first-page":"203","volume":"44","author":"J Krupi\u0144ski","year":"1993","unstructured":"Krupi\u0144ski J, Ka\u0142uza J, Kumar P, Kumar S, Wang JM. Some remarks on the growth-rate and angiogenesis of microvessels in ischemic stroke. Morphometric and immunocytochemical studies. Patol Pol. 1993;44(4):203\u20139.","journal-title":"Patol Pol"},{"issue":"8","key":"930_CR124","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1161\/STROKEAHA.111.642710","volume":"43","author":"A Ergul","year":"2012","unstructured":"Ergul A, Alhusban A, Fagan SC. Angiogenesis: a harmonized target for recovery after stroke. Stroke. 2012;43(8):2270\u20134.","journal-title":"Stroke."},{"issue":"5","key":"930_CR125","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1177\/0271678X19834158","volume":"39","author":"M Kanazawa","year":"2019","unstructured":"Kanazawa M, Takahashi T, Ishikawa M, Onodera O, Shimohata T, Del Zoppo GJ. Angiogenesis in the ischemic core: a potential treatment target? J Cereb Blood Flow Metab. 2019;39(5):753\u201369.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"12","key":"930_CR126","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1172\/JCI16929","volume":"111","author":"EW Lee","year":"2003","unstructured":"Lee EW, Michalkiewicz M, Kitlinska J, Kalezic I, Switalska H, Yoo P, et al. Neuropeptide Y induces ischemic angiogenesis and restores function of ischemic skeletal muscles. J Clin Invest. 2003;111(12):1853\u201362.","journal-title":"J Clin Invest"},{"issue":"9","key":"930_CR127","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1073\/pnas.0712303105","volume":"105","author":"D Stanic","year":"2008","unstructured":"Stanic D, Paratcha G, Ledda F, Herzog H, Kopin AS, H\u00f6kfelt T. Peptidergic influences on proliferation, migration, and placement of neural progenitors in the adult mouse forebrain. PNAS. 2008;105(9):3610\u20135.","journal-title":"PNAS"},{"key":"930_CR128","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejphar.2016.02.033","volume":"776","author":"R Saraf","year":"2016","unstructured":"Saraf R, Mahmood F, Amir R, Matyal R. Neuropeptide Y is an angiogenic factor in cardiovascular regeneration. Eur J Pharmacol. 2016;776:64\u201370.","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"930_CR129","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1161\/01.RES.83.2.187","volume":"83","author":"Z Zukowska-Grojec","year":"1998","unstructured":"Zukowska-Grojec Z, Karwatowska-Prokopczuk E, Rose W, Rone J, Movafagh S, Ji H, et al. Neuropeptide Y: a novel angiogenic factor from the sympathetic nerves and endothelium. Circ Res. 1998;83(2):187\u201395.","journal-title":"Circ Res"},{"key":"930_CR130","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0196-9781(01)00340-0","volume":"22","author":"G Ghersi","year":"2001","unstructured":"Ghersi G, Chen W, Lee EW, \u017bukowska Z. Critical role of dipeptidyl peptidase IV in neuropeptide Y-mediated endothelial cell migration in response to wounding. Peptides. 2001;22:453\u20138.","journal-title":"Peptides"},{"issue":"7","key":"930_CR131","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1073\/pnas.87.7.2628","volume":"87","author":"G Conn","year":"1990","unstructured":"Conn G, Bayne ML, Soderman DD, Kwok PW, Sullivan KA, Palisi TM, et al. Amino acid and cDNA sequences of a vascular endothelial cell mitogen that is homologous to platelet-derived growth factor. Proc Natl Acad Sci USA. 1990;87(7):2628\u201332.","journal-title":"Proc Natl Acad Sci USA"},{"key":"930_CR132","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0196-9781(01)00581-2","volume":"23","author":"J Kitli\u0144ska","year":"2002","unstructured":"Kitli\u0144ska J, Lee EW, Movafagh S, Pons J, Zukowska Z. Neuropeptide Y-induced angiogenesis in aging. Peptides. 2002;23:71\u20137.","journal-title":"Peptides"},{"key":"930_CR133","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1096\/fj.05-4770fje","volume":"20","author":"S Movafagh","year":"2006","unstructured":"Movafagh S, Hobson JP, Spiegel S, Kleinman HK, Zukowska Z. Neuropeptide Y induces migration, proliferation, and tube formation of endotheliual cells bimodally via Y1, Y2, and Y5 receptors. FASEB J. 2006;20:1327\u201337.","journal-title":"FASEB J"},{"key":"930_CR134","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3389\/fncel.2015.00085","volume":"9","author":"MC Geloso","year":"2015","unstructured":"Geloso MC, Corvino V, Di Maria V, Marchese E, Michetti F. Cellular targets for neuropeptide Y-mediated control of adult neurogenesis. Front Cell Neurosci. 2015;9:85.","journal-title":"Front Cell Neurosci"},{"issue":"6","key":"930_CR135","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1111\/j.1471-4159.2008.05334.x","volume":"105","author":"AR Alvaro","year":"2008","unstructured":"Alvaro AR, Martins J, Ara\u00fajo IM, Rosmaninho-Salgado J, Ambr\u00f3sio AF, Cavadas C. Neuropeptide Y stimulates retinal neural cell proliferation\u2013involvement of nitric oxide. J Neurochem. 2008;105(6):2501\u201310.","journal-title":"J Neurochem"},{"key":"930_CR136","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S0028-3908(02)00382-9","volume":"44","author":"AP Silva","year":"2003","unstructured":"Silva AP, Carvalho AP, Carvalho CM, Malva JO. Functional interaction between neuropeptide Y receptors and modulation of calcium channels in the rat hippocampus. Neuropharmacology. 2003;44:282\u201392.","journal-title":"Neuropharmacology"},{"issue":"4","key":"930_CR137","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/sj.jcbfm.9600573","volume":"28","author":"H Teng","year":"2008","unstructured":"Teng H, Zhang ZG, Wang L, Zhang RL, Zhang L, Morris D, et al. Coupling of angiogenesis and neurogenesis in cultured endothelial cells and neural progenitor cells after stroke. J Cereb Blood Flow Metab. 2008;28(4):764\u201371.","journal-title":"J Cereb Blood Flow Metab"},{"key":"930_CR138","doi-asserted-by":"crossref","first-page":"6880","DOI":"10.1523\/JNEUROSCI.4474-03.2004","volume":"24","author":"R Bright","year":"2004","unstructured":"Bright R, Raval AP, Dembner JM, P\u00e9rez-Pinz\u00f3n MA, Steinberg GK, Yenari MA, et al. Protein kinase C delta mediates cerebral reperfusion injury in vivo. J Neurosci. 2004;24:6880\u20138.","journal-title":"J Neurosci"},{"issue":"4","key":"930_CR139","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.tips.2017.01.003","volume":"8","author":"G Guidotti","year":"2017","unstructured":"Guidotti G, Brambilla L, Rossi D. Cell-penetrating peptides: from basic research to clinic. Trends Pharmacol Sci. 2017;8(4):406\u201324.","journal-title":"Trends Pharmacol Sci"}],"container-title":["Translational Stroke Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-021-00930-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12975-021-00930-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-021-00930-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T09:46:14Z","timestamp":1642499174000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12975-021-00930-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,22]]},"references-count":139,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["930"],"URL":"https:\/\/doi.org\/10.1007\/s12975-021-00930-4","relation":{},"ISSN":["1868-4483","1868-601X"],"issn-type":[{"value":"1868-4483","type":"print"},{"value":"1868-601X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,22]]},"assertion":[{"value":"18 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}